2-(3-Methoxy-phenylamino)-thiazole-4-carboxylic acid, 1g

2,2,2-Trifluoro-1-(1H-pyrrol-3-yl)ethanone, 97%, 250mg

3-Methyl-2-phenylpyrazole-4-carboxylic acid, 95.0%, 250mg

1-(3-PYRROLIDINYL)ETHANOL, 95.0%, 250mg

3-(5,6-Difluoro-1-oxoisoindolin-2-yl)piperidine-2,6-dione, 98%, 1g

5-Bromopyrimidine, 97.0%, 100g

(E)-2-(3,5-Dihydroxystyryl)benzene-1,3-diol, 95.0%, 25mg

tert-Butyl 1,2,3,4-tetrahydroisoquinolin-7-ylcarbamate, 95.0%, 250mg

2-Benzyl-3-tert-butoxycarbonylamino-propionic acid, 95.0%, 5g

(R)-4-((1H-indol-3-yl)methyl)oxazolidin-2-one, 98%, 1g

N-[(1,1-Dimethylethoxy)carbonyl]-N-methyl-L-tryptophan, 95%, 250mg

(2R,3R,4R,5S)-6-(Ethylamino)hexane-1,2,3,4,5-pentaol, 95.0%, 1kg

4-Chlorobenzoic acid, >=98%, for synthesis, 250 g, plastic packaging.